Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Deloitte
Cantor Fitzgerald
Medtronic
Farmers Insurance
Queensland Health
Johnson and Johnson
QuintilesIMS

Generated: May 26, 2018

DrugPatentWatch Database Preview

FACTREL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Factrel patents expire, and what generic alternatives are available?

Factrel is a drug marketed by West-ward Pharms Int and is included in one NDA.

The generic ingredient in FACTREL is gonadorelin hydrochloride. There are seven drug master file entries for this compound. Additional details are available on the gonadorelin hydrochloride profile page.
Summary for FACTREL
Drug patent expirations by year for FACTREL
Synonyms for FACTREL
6918-09-8
9034-40-6
A821811
AC1L1VXF
AM037788
AN-7551
AY-24031
C07607
C55H75N17O13
CHEMBL1981292
D04ODH
DB00644
Dirigestran
Dirigestran Spofa
DR003697
EINECS 251-553-1
Fertagyl
Fertagyl (TN)
Follicle-stimulating hormone-releasing factor (pig)
FSH-Releasing Hormone
FT-0628048
Glycinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolyl-
Gn-RH
GnRH-I
Gonadoliberin I
Gonadoliberin, Luliberin
Gonadorelin (INN)
Gonadorelin [INN:BAN]
Gonadorelin decapeptide
Gonadorelina
Gonadorelina [INN-Spanish]
Gonadoreline
Gonadorelinum
Gonadorelinum [INN-Latin]
Gonadotropin-releasing hormone
Gonadotropin-releasing hormone I
Gonadotropin, luteinizing hormone-releasing hormone, synthetic
HOE 471
Human LH-RH
Hypocrine
I06-0360
Kryptocur
L000690
LFRH
LH-FSH Releasing Hormone
LH-Releasing factor (pig)
LH-Releasing hormone (porcine)
LH-RH
LH-RH (swine)
LHFSH Releasing Hormone
LHFSHRH
LHRH
LHRH, human
LS-174422
Luforan
Lutal
Lutamin
LUTEINIZING HORMONE
Luteinizing hormone releasing hormone
Luteinizing hormone releasing hormone human
Luteinizing hormone-releasing factor (human)
Luteinizing hormone-releasing factor (pig)
Luteinizing hormone-releasing factor (rat)
Luteinizing hormone-releasing factor (sheep)
Luteinizing hormone-releasing factor (swine)
Luteinizing hormone-releasing hormone
Luteinizing hormone-releasing hormone (swin)
Lutrefact
Lutrepulse
Lutrepulse KIT
Mammalian GnRH
Mammalian gonadotropin-releasing hormone
Mammalian LH-RH
MammalianGnRH
MT-BT
N-[1-[[1-[[1-[[1-[[2-[[1-[[1-[2-[(2-azanyl-2-oxidanylidene-ethyl)carbamoyl]pyrrolidin-1-yl]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]
N-[1-[[1-[[1-[[1-[[2-[[1-[[1-[2-[[(2-amino-2-oxoethyl)amino]-oxomethyl]-1-pyrrolidinyl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-
N-[2-[[2-[[2-[[2-[[2-[[1-[[1-[2-[(2-amino-2-oxo-ethyl)carbamoyl]pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-
NCGC00182043-01
Ovine gonadotropin-releasing hormone
Ovine LH-RH
Porchine LH-RH
Porcine LH-releasing factor
pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
Relefact
Relisorm
Relisorm l
Synthetic decapeptide FSH/LH-RH
Synthetic Gn-RH
Synthetic gonadoliberin
Synthetic gonadotropic hormone-releasing hormone
Synthetic gonadotropin-releasing hormone
Synthetic LH-FSH releasing hormone
Synthetic LH-FSH-RH
Synthetic LH-releasing factor
Synthetic LH-releasing hormone
Synthetic LH-releasing hormone/FSH-releasing hormone
Synthetic LH-RF
Synthetic LH-RH
Synthetic LH-RH/FSH-RH
Synthetic LRF
XLXSAKCOAKORKW-UHFFFAOYSA-N

US Patents and Regulatory Information for FACTREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-002 Sep 30, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for FACTREL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-002 Sep 30, 1982 ➤ Sign Up ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 ➤ Sign Up ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 ➤ Sign Up ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Colorcon
US Army
Express Scripts
Queensland Health
Dow
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.